Stay updated on Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page.

Latest updates to the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page
- Check6 days agoChange DetectedNew sections for Contacts/Locations and Study Status were added in the study history, reflecting updated contact details and the current status of the trial. A prior entry dated 2026-04-17 was removed.SummaryDifference0.3%

- Check14 days agoChange DetectedThe page now shows Revision: v3.5.4 instead of v3.5.3, indicating a minor platform update; no study data or visible content appears to be altered.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedA new study record version was added to the record history with minor metadata updates, alongside a platform/software revision label. No substantive change to core study information (e.g., eligibility, interventions, outcomes, availability) is indicated by the provided differences.SummaryDifference0.3%

- Check42 days agoChange DetectedThe page revision tag updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a new history entry on 2026-03-24 for Study Status. The 2026-03-23 entry shows 56 changes, and the 2026-02-27 entry was removed.SummaryDifference0.2%

- Check71 days agoChange DetectedAdded a new Revision: v3.5.0 entry and removed Revision: v3.4.3 from the history.SummaryDifference0.1%

Stay in the know with updates to Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Zanidatamab Combo in HER2+ Gastric Cancer Clinical Trial page.